| Market revenue in 2025 | USD 1,935.5 million |
| Market revenue in 2033 | USD 8,232.6 million |
| Growth rate | 20.1% (CAGR from 2026 to 2033) |
| Largest segment | Wearables |
| Fastest growing segment | Smart Drugs |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Gene Modification Kits, Supplements, Mobile Apps, Implants (Chips), Smart Drugs, Wearables |
| Key market players worldwide | Apple Inc, Fitbit, Harvey Norman Holdings Ltd, The ODIN, Thync, Moodmetric, Thriveport, TrackMyStack, OsteoStrong San Jose |
Germany is at the forefront of biohacking innovation in Europe, with a robust medical technology sector and a highly developed research infrastructure. The country’s focus on precision medicine, regenerative therapies, and bioinformatics is driving advancements in the biohacking space. German consumers and professionals are embracing nootropics, performance-enhancing supplements, and biometric tracking for health optimization. Additionally, government funding for biotech startups and academic research is supporting the development of biohacking-related technologies.
Publish Date: Jun 29, 2026
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Apple Inc | View profile | 161,000 | One Apple Park Way, Cupertino, CA, United States, 95014 | www.apple.com |
| Fitbit | View profile | 251-500 | San Francisco, California, United States, North America | www.fitbit.com |
| Harvey Norman Holdings Ltd | View profile | 6,500 | A1 Richmond Road, Homebush West, Sydney, NSW, Australia, 2140 | www.harveynormanholdings.com.au |
| The ODIN | View profile | 1-10 | Oakland, California, United States, North America | the-odin.com/ |
| Thync | View profile | 1-10 | Menlo Park, California, United States, North America | www.thync.com/ |
| Moodmetric | View profile | 1-10 | Kouvola, Southern Finland, Finland, Europe | www.moodmetric.com |
| Thriveport | View profile | 11-50 | Los Angeles, California, United States, North America | www.thriveport.com |
| TrackMyStack | View profile | 1-10 | Toronto, Ontario, Canada, North America | trackmystack.com |
| OsteoStrong San Jose | View profile | - | San Jose, California, United States, North America | osteostrongsanjose.com/ |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biohacking Market Outlook will help companies and investors design strategic landscapes.
Wearables was the largest segment with a revenue share of 35.17% in 2025.
Horizon Databook has segmented the Germany biohacking market based on gene modification kits, supplements, mobile apps, implants (chips), smart drugs, wearables covering the revenue growth of each sub-segment from 2021 to 2033.
Germany is at the forefront of biohacking innovation in Europe, with a robust medical technology sector and a highly developed research infrastructure. The country’s focus on precision medicine, regenerative therapies, and bioinformatics is driving advancements in the biohacking space. German consumers and professionals are embracing nootropics, performance-enhancing supplements, and biometric tracking for health optimization. Additionally, government funding for biotech startups and academic research is supporting the development of biohacking-related technologies.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany Biohacking Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Germany Biohacking Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
